One step backwards for hepatitis B testing?

Serotonin receptor modulation in irritable bowel syndrome: one step forwards and one step backwards.

Comment The pharmacological treatment of irritable bowel syndrome (IBS) is currently far from satisfactory and there have been no new drug developments for many years. Recently, there has been a surge of interest in serotonin and the gut with particular emphasis, where IBS is concerned, on 5-HT3 and 5-HT4 receptors. A number of agonists and antagonists of these receptors are now under investiga...

Aptamer-based competitive binding assay for one-step quantitation of hepatitis B surface antigen.

An aptamer-based competitive binding assay for one-step (i.e. no requirement of pre-treatment) quantitation of target molecules of interest has been developed. This method has been successfully employed for the fast and sensitive detection of the surface antigen of the hepatitis B virus (HBsAg). The key features of our method include its low intrinsic background noise, low costs, high resolutio...

A Multistage Group Education for Hepatitis B

Abstract Introduction. Hepatitis B is the most common cause of end stage liver disease in Iran. As a high-cost disease with a relatively high incidence, and the relative lack of community knowledge, it warrants initiation of a public health intervention in Iran. Methods. This was a Before-After educational intervention that analyzed the data obtained from questionnaires filled out by 80 pat...

One step forward

One step backwards, two steps ahead: amplifying movement errors to improve walking post-stroke.